Works matching IS 14783223 AND DT 2009 AND VI 29 AND IP 2


Results: 31
    1
    2
    3
    4
    5

    Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.

    Published in:
    Liver International, 2009, v. 29, n. 2, p. 213, doi. 10.1111/j.1478-3231.2008.01853.x
    By:
    • Eguchi, Yuichiro;
    • Mizuta, Toshihiko;
    • Ishibashi, Eriko;
    • Kitajima, Yoichiro;
    • Oza, Noriko;
    • Nakashita, Shunya;
    • Hara, Megumi;
    • Iwane, Shinji;
    • Takahashi, Hirokazu;
    • Akiyama, Takumi;
    • Ario, Keisuke;
    • Kawaguchi, Yasunori;
    • Yasutake, Tsutomu;
    • Iwakiri, Ryuichi;
    • Ozaki, Iwata;
    • Hisatomi, Akitaka;
    • Eguchi, Takahisa;
    • Ono, Naofumi;
    • Fujimoto, Kazuma
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-κB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-α.

    Published in:
    Liver International, 2009, v. 29, n. 2, p. 291, doi. 10.1111/j.1478-3231.2008.01858.x
    By:
    • Itatsu, ,4Keita;
    • Sasaki, Motoko;
    • Harada, Kenichi;
    • Yamaguchi, Junpei;
    • Ikeda, Hiroko;
    • Sato, Yasunori;
    • Ohta, Tetsuo;
    • Sato, Hiroshi;
    • Nagino, Masato;
    • Nimura, Yuji;
    • Nakanuma, Yasuni
    Publication type:
    Article
    20
    21
    22
    23
    24

    Homocysteine levels and sustained virological response to pegylated-interferon α2b plus ribavirin therapy for chronic hepatitis C: a prospective study.

    Published in:
    Liver International, 2009, v. 29, n. 2, p. 248, doi. 10.1111/j.1478-3231.2008.01832.x
    By:
    • Borgia, Guglielmo;
    • Gentile, Ivan;
    • Fortunato, Giuliana;
    • Borrelli, Francesco;
    • Borelli, Salvatore;
    • de Caterina, Maurizio;
    • Di Taranto, Maria Donata;
    • Simone, Maria;
    • Borgia, Federico;
    • Viola, Chiara;
    • Reynaud, Laura;
    • Cerini, Raimondo;
    • Sacchetti, Lucia
    Publication type:
    Article
    25
    26

    Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS<sup>®</sup>) plus ribavirin (COPEGUS<sup>®</sup>) for 16 or 24 weeks.

    Published in:
    Liver International, 2009, v. 29, n. 2, p. 237, doi. 10.1111/j.1478-3231.2008.01859.x
    By:
    • Rodriguez-Torres, Maribel;
    • Govindarajan, Sugantha;
    • Diago, Moises;
    • Morgan, Thomas;
    • Anand, Bhupinderjit;
    • Barange, Karl;
    • Suter, Frank;
    • Lin, Amy;
    • Hooper, Gregory;
    • Shiffman, Mitchell
    Publication type:
    Article
    27
    28
    29
    31